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were compared between curcumin and placebo conditions 
by two-way repeated measures ANOVA.
Results MVC torque decreased smaller and recov-
ered faster (e.g., 4 days post-exercise: −31 ± 13 % vs. 
−15 ± 15 %), and peak serum CK activity was smaller 
(peak: 7684 ± 8959 IU/L vs. 3398 ± 3562 IU/L) for cur-
cumin than placebo condition (P < 0.05). However, no 
significant differences between conditions were evident 
for other variables, and no significant changes in IL-6 and 
TNF-α were evident after exercise.
Conclusion It is concluded that theracurmin ingestion 
attenuates some aspects of muscle damage such as MVC 
loss and CK activity increase.
Keywords Polyphenolic · Elbow flexors · Muscle 
strength · Muscle soreness · Supplement · Creatine kinase
Abbreviations
CK  Creatine kinase
DOMS  Delayed onset muscle soreness
IL-6  Interleukin 6
MVC  Maximal voluntary contraction
ROM  Range of motion
TNF-α  Tumor necrosis factor-α
VAS  Visual analog scale
Introduction
Unaccustomed exercise, especially that consists of high-
intensity and/or large number of eccentric (lengthening) 
contractions, induces muscle damage (Clarkson et al. 
1992). Eccentric exercise-induced muscle damage is indi-
cated by prolonged decreases in muscle strength and range 
of motion (ROM), swelling, delayed onset muscle soreness 
Abstract 
Purpose Polyphenolic curcumin is known to have potent 
anti-inflammatory effects; thus the present study investi-
gated the hypothesis that curcumin ingestion would attenu-
ate muscle damage after eccentric exercise.
Methods Fourteen untrained young men (24 ± 1 years) 
performed 50 maximal isokinetic (120°/s) eccentric con-
tractions of the elbow flexors of one arm on an isokinetic 
dynamometer and the same exercise with the other arm 
4 weeks later. They took 150 mg of curcumin (theracur-
min) or placebo (starch) orally before and 12 h after each 
eccentric exercise bout in a randomised, crossover design. 
Maximal voluntary contraction (MVC) torque of the elbow 
flexors, range of motion of the elbow joint, upper-arm cir-
cumference, muscle soreness, serum creatine kinase (CK) 
activity, and plasma interleukin-6 (IL-6) and tumor necro-
sis factor-α (TNF-α) concentration were measured before, 
immediately after, and 24, 48, 72 and 96 h after each 
eccentric exercise. Changes in these variables over time 
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(DOMS), and increased muscle proteins in the blood such 
as creatine kinase (CK) activity (Warren et al. 1999). Mus-
cle damage initiates inflammatory responses, resulting in 
secondary muscle damage (Tiidus 1998). The impairment 
of muscle function caused by damage and subsequent 
inflammatory responses could reduce the ability to perform 
daily activities and athletic performance. Thus, it is impor-
tant to prevent or minimise muscle damage after exercise 
by attenuating inflammatory responses. One of many meas-
ures for this purpose could be an oral intake of anti-inflam-
matory substances (Connolly et al. 2003).
Several studies have shown that some anti-inflammatory 
substance supplementations are beneficial for attenuating 
eccentric exercise-induced muscle damage (Connolly et al. 
2006; Howatson et al. 2010; Trombold et al. 2010), but 
other did not find such effect (O’Fallon et al. 2012). These 
inconsistent results may, in part, be due to the differences in 
substances, exercise model and experimental design among 
studies. It has been reported that tart cherry juice consump-
tion enhanced recovery of muscle strength and attenuated 
interleukin-6 (IL-6) and C-reactive protein responses after 
marathon running (Howatson et al. 2010) and prolonged 
upper arm exercise (Connolly et al. 2006). Other study 
showed that taking polyphenol ellagitannins from pome-
granate extract before and after high-intensity elbow flexor 
eccentric exercise attenuated muscle strength loss by 10 % 
(Trombold et al. 2010). In contrast, O’Fallon et al. (2012) 
reported that ingestion of a polyphenol flavonoid from 
quercetin before and after exercise did not affect changes 
in maximal voluntary contraction (MVC) strength, ROM, 
serum CK activity, IL-6 and tumor necrosis factor-α (TNF-
α) and DOMS after elbow flexor eccentric contractions.
Curcumin, extracted from turmeric, is a natural poly-
phenolic substance. It has been demonstrated that cur-
cumin has anti-inflammatory effect by downregulating the 
nuclear factor-kappa B (NF-kB), thereby suppressing the 
expression of IL-6 and TNF-α (Cho et al. 2007; Aggarwal 
et al. 2006). The anti-inflammatory effects of curcumin 
have been used in the treatment of rheumatoid arthritis, 
inflammatory bowel disease, multiple sclerosis and diabe-
tes (Sethi et al. 2009). Usharani et al. (2008) demonstrated 
that 600 mg of daily curcumin intake for 8 weeks reduced 
approximately 60 % of plasma IL-6 and TNF-α concen-
trations in diabetes mellitus patients. Polyphenol supple-
mentation of curcumin has been reported to blunt IL-6 and 
TNF-α increases in mice muscle after downhill running 
(Davis et al. 2007). Kawanishi et al. (2013) have recently 
reported that oral curcumin ingestion (3 mg) suppresses 
oxidative stress, reducing hydrogen peroxide in skeletal 
muscle following downhill running-induced muscle dam-
age in mice. Thus, it is possible that curcumin supplemen-
tation is effective for attenuating eccentric exercise-induced 
muscle damage in humans. However, to the best of our 
knowledge, no previous human study has examined the 
effects of curcumin ingestion on markers of muscle damage 
after eccentric exercise.
The purpose of this study, therefore, was to examine 
the acute effect of curcumin intake before and 12 h post-
exercise on changes in indirect markers of muscle damage 
and inflammation after eccentric elbow flexors exercise. It 
was hypothesised that curcumin ingestion would attenuate 
the changes in indirect muscle damage markers and inflam-
matory markers in the blood after eccentric exercise when 
compared with placebo condition.
Methods
Subjects
The present study recruited 14 healthy, untrained young 
men who had not been involved in any regular resistance 
training for at least 1 year before this study. Their aver-
age ± SD age, height and body mass were 23.5 ± 2.3 years, 
172.1 ± 7.5 cm and 65.2 ± 11.3 kg, respectively. The sam-
ple size was estimated on the assumption that the curcumin 
ingestion could attenuate the decrease in muscle strength in 
recovery days by at least 25 %, if it was effective. On the 
basis of the power of 0.80 and alpha level of 0.05, a sample 
size of 10 was found to be necessary based on the data of a 
previous study (Evans et al. 2002) in which a similar eccen-
tric exercise to that of the present study was performed. 
Subjects maintained their normal food intake and lifestyle 
habits, but abstained from strenuous physical activities, 
and did not take anti-inflammatory drugs during the study 
period. All subjects gave their written informed consent to 
participate in the study, and all procedures were reviewed 
and approved by the ethical committee of the University of 
Tsukuba.
Experimental design
This study used a crossover design in which one arm was 
used for curcumin condition, and the other arm was used 
for placebo condition in a randomised, single-blinded fash-
ion. This design requires a smaller number of participants, 
and it has been reported that a within-subject (contralateral 
arm) design is an alternative to a between-subject design if 
the order of exercise is counterbalanced by arm dominance 
(Newton et al. 2013).
Each arm performed a bout of eccentric exercise of the 
elbow flexors separated by 4 weeks, and the use of dom-
inant-nondominant arms and the order of the conditions 
were counterbalanced among the subjects. Dependent 
variables consisted of MVC torque of the elbow flexors, 
ROM of the elbow joint, upper-arm circumference, muscle 
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soreness, serum CK activity, and plasma IL-6 and TNF-α 
concentrations. Changes in these variables before, immedi-
ately after and 24, 48, 72 and 96 h after the exercise were 
compared between the curcumin and placebo conditions.
Curcumin and placebo
We developed theracurmin (Theravalues Corporation, 
Japan) using a microparticulation and surface process-
ing technique, and theracurmin has been shown to result 
in much higher plasma concentration and bioavailabil-
ity after intake when compared with conventional cur-
cumin powder (Sasaki et al. 2011). As a placebo, starch 
was used, which was contained in an identical capsule as 
that of the curcumin, so the subjects could not distinguish 
between them. Six capsules of 25 mg of curcumin or pla-
cebo were administered 1 hour before (150 mg) and 12 h 
after exercise (150 mg). It has been reported that post-
exercise inflammation starts to present around 4–12 h after 
eccentric exercise, and further develops in 24–48 h after 
exercise (Paulsen et al. 2012; Davis et al. 2007). Consider-
ing the time taken for the curcumin to get into the blood 
stream, and its remaining time in the blood, it was assumed 
that the ingestion at 1 h before exercise could attenuate the 
initial inflammation, and that at 12 h after exercise could 
attenuate the development of inflammation before 24 h 
post-exercise. The amount (150 mg) has been shown to be 
safe for one time dose (Kanai et al. 2012). However, it had 
not been known before this study how much of curcumin 
would be effective to prevent muscle damage in humans, 
so we assumed that a significant difference between the 
curcumin and placebo conditions would be shown by the 
dose (150 mg before and 12 h after exercise, 300 mg/day), 
if any positive effect of curcumin ingestion on muscle dam-
age existed.
Eccentric exercise
All subjects performed two bouts of eccentric exercise of 
the elbow flexors on a BIODEX dynamometer (BIODEX 
System 3, USA), using one arm for each bout separated 
by 4 weeks. Each subject was seated on the dynamom-
eter chair with the arm being supported by padded armrest 
secured at 45° shoulder flexion and the waist and chest 
being stabilised with straps. The exercise consisted of 50 
maximal eccentric contractions of the elbow flexors at an 
angular velocity 120°/s, and the range of motion was from 
130° and to 10° elbow flexion, where a fully extended 
elbow joint angle was considered to be 0°, thus each con-
traction time was 1 s (Evans et al. 2002). The exercise limb 
was passively returned to the initial position at 10°/s, cre-
ating a 12-s rest between contractions. The subjects were 
instructed to contract the elbow flexors maximally to resist 
the elbow extending action of the dynamometer for the 
whole range of motion. Total work and peak torque were 
calculated using the BIODEX System software.
Muscle damage markers
Several indirect markers of muscle damage, which were 
often used in previous studies (Nosaka et al. 2002a, b), 
were measured before, immediately after, and 24, 48, 72 
and 96 h after each exercise bout. The details of the mark-
ers are shown below. The test–retest reliability of each 
measure was determined using two baseline measurements 
performed before exercise by an interclass correlation coef-
ficient (R) and coefficient of variation (CV). The R and CV 
(shown in parentheses) values for MVC torque, ROM and 
upper-arm circumference were 0.99 (2.9 %), 0.97 (1.1 %) 
and 1.00 (0.2 %), respectively. The muscle soreness was 
not assessed for the reliability, because all participants 
recorded DOMS scores as zero for palpation during the 
familiarisation sessions. The intra-assay CV was 5.3 % for 
CK activity, 3.2 % for IL-6 and 10.0 % for TNF-α in a pilot 
study using five men.
MVC torque
MVC torque of the exercised elbow flexors was measured 
using the isokinetic dynamometer in the same positioning 
as that of the eccentric exercise, and the elbow joint angle 
was set at 90°. Three 5-s maximal isometric contractions 
were performed with a 30-s rest between trials, and the 
highest value of the three trials was used for further analy-
sis (Nosaka et al. 2002a).
ROM
According to the protocol of the previous study (Nosaka 
et al. 2006), each subject was asked to actively extend the 
elbow joint maximally (extended elbow joint angle) and 
to touch shoulder of the same side with the hand (flexed 
elbow joint angle). The ROM was determined as the differ-
ence between the two elbow joint angles. Each angle was 
measured by a goniometer three times, and the mean of the 
three measures was used for the calculation of ROM.
Upper‑arm circumference
To assess muscle swelling, upper-arm circumference was 
assessed at the mid-belly of biceps brachii muscle (60 % 
distal to the length between the acromial process and epi-
condylus lateralis humeri) using a standard tape measure 
(Evans et al. 2002). The measurements were taken three 
times, and mean value of the three measurements was used 
for further analysis.
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Muscle soreness
Muscle soreness upon palpation of the upper-arm and pas-
sively extending the elbow joint was quantified by a visual 
analog scale (VAS) that had a 100-mm line with “no pain” 
on one end and “extremely sore” on the other end (Chen 
and Nosaka 2006). The subjects were instructed to sit with 
arm relaxed, and the investigator palpated over the biceps 
brachii, and extended the elbow joint maximally. The same 
investigator performed all tests and the pressure of palpa-
tion was kept as constant as possible between subjects and 
between days.
Blood sampling and analyses
Blood was taken from the antecubital vein by a stand-
ard venipuncture technique. To obtain serum for CK 
activity analysis, 9 ml blood sample was collected using 
commercially produced vacuum-sealed serum collec-
tion tube (SEKISUI Medical Company Limited, Japan). 
To obtain the plasma for curcumin, IL-6, and TNF-α 
analyses, 5 ml blood sample was collected using a tube 
containing ethlenediaminetetraacetic acid (Terumo cor-
poration, Japan). These were centrifuged at 3000 rpm 
for 15 min at 4 °C, and the serum and plasma samples 
were stored at −80 °C until analysis. Plasma curcumin 
concentration was measured by a HPLC–MS/MS sys-
tem consisting of a Prominence micro-C system (Shi-
madzu, Kyoto, Japan) and an API 3200 tandem mass 
spectrometer (Applied Biosystems CA, USA). Serum 
CK activity was measured using a test kit (L-type CK, 
Wako Pure Chemical Industries, Japan) by a commer-
cial laboratory. The normal reference range for male 
adults with this method is 48–259 IU/L. The concentra-
tions of plasma IL-6 and TNF-α were determined using 
a commercial enzyme-linked immunosorbent assay kit 
(Quantikine Human IL-6, TNF-α R & D system Inc. 
Minneapolis, USA).
Statistical analyses
Changes in the dependent variables over time were com-
pared between the curcumin and placebo conditions by a 
two-way repeated-measures ANOVA. When the ANOVA 
showed a significant interaction effect, a Tukey’s post hoc 
test was used to locate differences between conditions. A 
Tukey’s post hoc test was also used to compare the pre-
exercise and post-exercise values for each bout separately, 
when a significant time effect was found by the ANOVA. 
Inter-group comparison for the total work and mean eccen-
tric peak torque during the exercise were made by a paired 
t test. Since a Kolmogorov-Smirov test showed that serum 
CK activity data was not normally distributed, the peak 
serum CK activity was compared between the condition 
using a non-parametric Wilcoxon’s rank test. The level 
of statistical significance was set at P < 0.05. All data are 
shown as mean ± standard deviation (SD).
Results
Plasma curcumin concentration
There was no difference in plasma curcumin concentra-
tion at baseline between curcumin and placebo condi-
tions, but a significant interaction effect was evident for 
the changes after exercise (Fig. 1). Plasma curcumin con-
centration increased from baseline (0.04 ± 0.07 ng/mL) 
to 127.7 ± 144.6, 85.7 ± 51.6, 8.6 ± 5.5, 2.2 ± 1.4 and 
0.9 ± 0.6 ng/mL at 0, 24, 48, 72 and 96 h after exercise, 
respectively, for the curcumin condition. However, in the 
placebo condition, no significant changes in plasma cur-
cumin concentration were observed from the baseline 
(0.01 ± 0.05 ng/mL) at any time points after exercise 
(0.02 ± 0.05, 0.02 ± 0.04, 0.03 ± 0.08, 0.03 ± 0.04 and 
0.01 ± 0.02 ng/mL at 0, 24, 48, 72 and 96 h post-exercise, 
respectively).
Exercise
The total work (2815 ± 788 J vs. 3011 ± 756 J, P = 0.178) 
and mean peak torque (40 ± 11 Nm vs. 41 ± 9 Nm, 
P = 0.597) during eccentric exercise did not differ between 
curcumin and placebo conditions.
Fig. 1  Changes (mean ± SD) in plasma curcumin concentration 
from the baseline (Pre), immediately (0) and 24–96 h after eccen-
tric exercise of the elbow flexors for the curcumin and placebo sup-
plementation conditions. *P < 0.05 vs. Pre; †P < 0.05 vs. placebo; 
P < 0.05: a significant interaction effect
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MVC torque
The MVC torque before exercise was not significantly dif-
ferent between curcumin (52.5 ± 10.3 Nm) and placebo 
(55.1 ± 8.8 Nm) conditions. As shown in Fig. 2, a signifi-
cant interaction effect was evident for the changes in MVC 
torque. The change in MVC from baseline was signifi-
cantly smaller for the curcumin condition (33.0 ± 8.0 %) 
compared with placebo condition (40.0 ± 9.1 %) at imme-
diately after exercise and also at 48–96 h after exercise by 
13–16 %.
ROM
At the baseline, ROM was similar between curcumin 
(134° ± 4°) and placebo (133° ± 5°) conditions. After 
eccentric exercise, ROM significantly decreased at all 
measurement time points from the baseline, but no signifi-
cant interaction effect was evident for the changes between 
conditions (Fig. 3).
Upper‑arm circumference
There was no significant difference in the baseline upper-
arm circumference between curcumin (25.7 ± 2.5 cm) and 
placebo (25.9 ± 2.8 cm) conditions. Upper-arm circumfer-
ence significantly increased after exercise by 3 % at 96 h 
post-exercise for both conditions, but no significant differ-
ences between conditions were found (Fig. 4).
Muscle soreness
Significant increases in VAS were observed between 24 and 
96 h after eccentric exercise for both conditions, and the 
peak VAS upon palpation was 5.5 ± 2.1 cm for curcumin 
and 6.0 ± 2.2 cm for placebo condition, but no significant 
interaction effect was evident (Fig. 5). This was also the 
case for the VAS with elbow joint extension, and the values 
were similar to those shown by the palpation.
Serum CK activity
Serum CK activity was within normal reference range 
prior to exercise without any significant difference 
between the curcumin (118 ± 49 IU/L) and control 
(115 ± 47 IU/L) conditions. Although the changes in 
serum CK activity after eccentric exercise were not sta-
tistically different between conditions (Fig. 6, P = 0.052), 
peak CK activity was significantly smaller for curcumin 
condition (3398 ± 3562 IU/L) than placebo condition 
(7684 ± 8959 IU/L).
Plasma IL‑6 and TNF‑α concentration
Plasma IL-6 and TNF-α concentrations were not differ-
ent between groups before exercise (IL-6 0.83 ± 0.22 vs. 
0.73 ± 0.18 ng/mL, TNF-α 1.85 ± 0.74 vs. 1.63 ± 0.35 ng/
mL, for curcumin and placebo, respectively). They did not 
change significantly after eccentric exercise, and no signifi-
cant differences were found between curcumin and placebo 
conditions (Fig. 7).
Fig. 2  Normalised changes (mean ± SD) in maximal voluntary iso-
metric contraction (MVC) torque from the baseline (Pre), at immedi-
ately (0) and 24–96 h after eccentric exercise of the elbow flexors for 
the curcumin and placebo supplementation conditions. *P < 0.05 vs. 
Pre; †P < 0.05 vs. placebo; P < 0.05: a significant interaction effect
Fig. 3  Absolute changes (mean ± SD) in range of motion (ROM) 
from the baseline (Pre) at immediately (0) and 24–96 h after eccentric 
exercise of the elbow flexors for the curcumin and placebo supple-
mentation conditions. *P < 0.05 vs. Pre; NS no significant interaction 
effect
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Discussion
This study investigated whether curcumin (theracurmin) 
ingestion at 1 h before and 12 h after eccentric exercise 
would attenuate muscle damage in healthy young men. The 
main findings of the study include that (1) plasma curcumin 
concentration elevated from the baseline after exercise 
only for curcumin condition (Fig. 1); (2) the magnitude 
Fig. 4  Absolute changes (mean ± SD) in upper-arm circumference 
(CIR) from the baseline (Pre) at immediately (0) and 24–96 h after 
eccentric exercise of the elbow flexors for the curcumin and placebo 
supplementation conditions. *P < 0.05 vs. Pre; NS no significant 
interaction effect
Fig. 5  Muscle soreness upon palpation of biceps brachii 
(mean ± SD) assessed by a visual analog scale (10 cm) before (Pre), 
immediately after (0) and 24–96 h after eccentric exercise of the 
elbow flexors for the curcumin and placebo supplementation condi-
tions. *P < 0.05 vs. Pre; NS no significant interaction effect
Fig. 6  Changes (mean ± SD) in serum CK activity before (Pre), 
immediately after (0) and 24–96 h after eccentric exercise of the 
elbow flexors for the curcumin and placebo supplementation condi-
tions. *P < 0.05 vs. Pre; An inset, peak serum CK activity for the cur-
cumin (C) and placebo (P) conditions is shown; †P < 0.05 vs. placebo
Fig. 7  Changes (mean ± SD) in plasma IL-6 (a) and TNF-α (b) 
concentrations before (Pre), immediately after (0) and 24–96 h after 
eccentric exercise of the elbow flexors for the curcumin and placebo 
supplementation conditions. NS no significant interaction effect
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of decrease in MVC torque was significantly smaller for 
curcumin than placebo condition (Fig. 2), (3) peak serum 
CK activity was significantly reduced in the curcumin than 
placebo condition (Fig. 6), but (4) no significant differ-
ences between the conditions were evident for other vari-
ables (Figs. 3, 4, 5, 7). These results did not fully support 
the hypothesis that curcumin ingestion would attenuate the 
changes in the muscle damage markers after eccentric exer-
cise, but showed that the curcumin was effective for some 
aspects of muscle damage.
The present study used an arm-to-arm comparison 
model, and the test order of curcumin and placebo condi-
tions, as well as the use of the dominant and nondominant 
arms, were counterbalanced among subjects. The total work 
and mean peak torques during eccentric exercise did not dif-
fer between conditions. Although a small (7 %) non-signif-
icant difference in the total work was observed between the 
conditions, the total work did not correlate with the magni-
tude of decrease in MVC torque. Thus, it seems reasonable 
to expect that changes in the dependent variables were simi-
lar between the conditions, if curcumin ingestion had not 
produced any effects. However, the magnitude of decline 
in MVC torque immediately after exercise for the curcumin 
condition (33 %) was significantly smaller than that of the 
placebo condition (40 %), and this difference was sustained 
in the recovery days (Fig. 2). These indicate that the cur-
cumin ingestion immediately before and/or 12 h after exer-
cise affected the changes in MVC torque.
Trombold et al. (2010) showed that daily ellagitannin 
intake reduced loss of isometric elbow flexion strength by 
10 % at 48 and 72 h after exercise. Connolly et al. (2006) 
reported that cherry juice ingestion for 4 days before and 
for 4 days after exercise attenuated muscle strength loss by 
20 %. These authors speculated that anti-inflammatory and/
or anti-oxidant effect of the substances decreased second-
ary muscle damage responses such as increases in vascular 
permeability, neutrophil and free radical, attenuating mus-
cle fibre disruption (Connolly et al. 2006; Trombold et al. 
2010). It is important to note that increases in serum CK 
activity were also attenuated by the curcumin ingestion in 
the present study (Fig. 6). Increases in CK activity in the 
blood indicate disruption of plasma membrane of muscle 
fibres and are commonly used as a marker of muscle fibre 
damage (Clarkson et al. 1992). It was reported that mor-
phological disruption of myofibrils was associated with the 
magnitude of decrease in muscle function (Raastad et al. 
2010). In the present study, the smaller increases in serum 
CK activity in the curcumin condition compared with the 
placebo condition may suggest that myofibril damage was 
attenuated by curcumin ingestion. This might be associated 
with the smaller decreases in MVC torque for the curcumin 
condition. Moriyuki et al. (2010) reported that curcumin 
inhibited production of prostaglandin via suppression 
of cyclooxygenase-2 upregulation and NF-kB signals, 
implying that curcumin ingestion might decrease vascular 
permeability. It may be that curcumin stabilises plasma 
membrane, which might be associated with the attenuated 
increase in serum CK activity and decrease in MVC torque 
after eccentric exercise. It is necessary to investigate the 
effects of curcumin on plasma membrane and myofibrils 
damage in future studies.
The present study found that curcumin ingestion had no 
positive effects on ROM (Fig. 3), swelling (Fig. 4), DOMS 
(Fig. 5) and blood markers (IL-6 and TNF-α) of inflamma-
tion (Fig. 7). Changes in ROM, upper-arm circumference 
and DOMS after eccentric exercise were similar to those 
reported in previous studies (Evans et al. 2002; Nosaka 
et al. 2006). It was expected that curcumin ingestion would 
reduce the magnitude of decrease in ROM and increase 
in upper-arm circumference and DOMS; however, no 
such effects were found (Figs. 3, 4, 5). Davis et al. (2007) 
showed curcumin ingestion (10 mg) in mice (consider-
ing the body weight difference, it would be 10,000 mg in 
human) attenuated IL-6 and TNF-α elevation following 
eccentric exercise. Comparing to this animal study, the 
amount of curcumin (150 mg × 2) was small in the present 
study. However, it is known that curcumin is highly lipo-
philic and poorly bioavailabe, and that more than 8000 mg 
of curcumin intake did not necessarily increase blood cur-
cumin concentration in human (Kanai et al. 2012). In con-
trast, the theracurmin that was used in the present study 
was highly absorbable and more bioavailable when com-
pared with conventional curcumin powder (Sasaki et al. 
2011). It is not known how equivalent the amount of thera-
curmin used in the present study (150 mg × 2) was to that 
of the previous studies that used conventional curcumin 
powder (e.g. 8000 mg). The subjects ingested theracurmin 
before exercise and 12 h after exercise, which resulted in 
prolonged increases in plasma curcumin concentration 
above the baseline for 96 h after exercise for the curcumin 
condition, although the level of plasma curcumin con-
centration was low (8 < ng/mL) at 48–96 h post-exercise 
(Fig. 1). Although the range of the subject’s body mass 
was relatively large (50–91 kg), there was no relation-
ship between plasma curcumin concentration and body 
mass. A previous study showed that ingestion of theracur-
min (150 mg) increased plasma curcumin concentration 
already at 1 h post-ingestion, and its half-life time was 12 h 
in healthy adults (Kanai et al. 2012). Thus, it is assumed 
that the amount of curcumin for each time point (150 mg) 
was adequate to provide anti-inflammatory effects, if the 
supplement had such effects. However, the present study 
found a significant effect of theracurmin supplementation 
before and after exercise on MVC torque and CK activity 
only, and no effects on ROM, muscle soreness and swell-
ing. Nosaka et al. (2006) reported that essential amino acid 
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supplementation given 30 min before and immediately after 
eccentric exercise (total of 7.2 g) did not affect any indi-
cators of muscle damage, but when the supplementation 
was continued in next 4 days after exercise (morning and 
evening for ten times over 5 days, total of 36 g) attenuated 
increase in muscle soreness and ROM. Thus, it is possible 
that the effects of curcumin supplementation on DOMS 
and swelling would have been found, if the curcumin had 
been given on recovery days (e.g. 1–4 days post-exercise). 
There are many possible supplementation conditions in 
terms of dose, frequency and time points; a series of stud-
ies are warranted to investigate whether a larger dose and 
more frequent theracurmin supplementation in recovery 
days after eccentric exercise will provide greater effects on 
muscle damage.
The polyphenolic component of curcumin exerts anti-
inflammatory effects via downregulation of NF-κB, which 
decreases in the expression of inflammatory cytokines 
such as IL-6 and TNF-α (Jobin et al. 1999; Shishodia et al. 
2007; Davis et al. 2007). Thus, we expected to see smaller 
increases in IL-6 and TNF-α after eccentric exercise for the 
curcumin than placebo condition; however, no significant 
differences between conditions were found, and they did 
not change significantly for either condition (Fig. 7). Hirose 
et al. (2004) showed no significant changes in IL-6 and 
TNF-α at 24–96 h after elbow flexor eccentric exercise and 
explained that the short exercise time and the small muscle 
mass involved in the exercise did not affect the inflamma-
tory cytokine levels in the blood. Philippou et al. (2009) 
reported that knee extensor eccentric contractions increased 
serum IL-6 concentrations at 6 and 48 h post-exercise, but 
Miles et al. (2008) showed that IL-6 increased at 8 and 12 h, 
and returned to the baseline level at 24 h after elbow flexor 
eccentric exercise. Depner et al. (2010) reported that TNF-α 
concentration did not change, but IL-6 decreased by 20 % 
at 1.5 and 4 h after eccentric exercise of the elbow flex-
ors and extensors. Thus, it might be that the present study 
missed the changes in IL-6 and TNF-α, because no blood 
samples were taken between immediately and 24 h after 
exercise. It is also interesting to assess other cytokines (e.g. 
IL-8, IL-10) and inflammatory markers (e.g. C-reactive pro-
tein) in future studies. Previous animal studies have reported 
that curcumin ingestion attenuated increases in inflamma-
tory cytokine (e.g., IL-6 and TNF-α) in the soleus muscle 
and oxidative stress markers (e.g., hydrogen peroxide and 
NADPH-oxidase) in the gastrocnemius muscle at 24 and 
48 h after downhill running (Davis et al. 2007; Kawanishi 
et al. 2013). Therefore, it is also important to examine the 
effects of curcumin ingestion on inflammatory cytokines 
and oxidative stress marker in human skeletal muscles.
Many studies that investigated the effect of nutritional 
supplementation on muscle function have failed to find 
positive effect on muscle function (Nosaka et al. 2006; 
Bryer and Goldfarb 2006; O’Fallon et al. 2012). How-
ever, the present study demonstrated that highly bioavail-
able curcumin attenuated the loss of muscle function after 
eccentric exercise. This may be important for athletes who 
train and compete regularly, since curcumin ingestion could 
help them to reduce prolonged loss of muscle function in 
an intense competition season. However, it should be noted 
that the present study used untrained men as the subjects 
and thus the findings of the present study cannot be gen-
eralised to other population such as women and trained 
individuals. Further studies are necessary to test women 
and trained individuals for the effects of curcumin supple-
mentation on eccentric exercise-induced muscle damage. 
Furthermore, if curcumin supplementation provides strong 
anti-inflammatory effects, it should be investigated whether 
chronic curcumin intake attenuates muscle adaptations 
induced by resistance training. Trappe et al. (2001) reported 
that ibuprofen blunted protein synthesis after knee extensor 
eccentric exercise. Thus, it might be that chronic consump-
tion of curcumin blunts muscle hypertrophy. The chronic 
supplementation of curcumin warrants further studies.
In conclusion, the present study demonstrated that the 
decrease in muscle strength and increase in serum CK activ-
ity after eccentric exercise were attenuated by highly bioa-
vailable curcumin intake at 1 h before and 12 h after eccentric 
exercise of the elbow flexors in untrained men. These findings 
suggest that curcumin intake has some beneficial effects on 
recovery of eccentric exercise-induced muscle damage.
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